StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) Announces Positive Phase 2 Data in Alopecia Areata at 2018 EADV Congress
September 17, 2018 5:50 AM
Pfizer Inc. (NYSE: PFE) today announced results from its Phase 2a study of PF-06651600, an oral Janus kinase (JAK) 3 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Management Comments
Next Articles
Pfizer (PFE) Announces Evaluation Agreement with Atomwise Inc.
September 17, 2018 8:10 AM
Pfizer Presents Positive Phase 2 Data in Alopecia Areata During Late-Breaker Session at the 27th European Academy of Dermatology and Venereology (EADV) Congress
September 15, 2018 2:00 AM
Roche steps up efficiency drive to take sting out of biosimilars
September 13, 2018 12:49 PM
Mylan N.V. (MYL) Gains on Chatter
September 13, 2018 9:49 AM